Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA lists Camber Pharmaceuticals' lisdexamfetamine dimesylate as an approved original application (generic) product. The approval covers the same indications as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)